Annual CFO
-$519.00 K
+$405.00 K+43.83%
31 December 2023
Summary:
STRATA Skin Sciences annual cash flow from operations is currently -$519.00 thousand, with the most recent change of +$405.00 thousand (+43.83%) on 31 December 2023. During the last 3 years, it has fallen by -$2.62 million (-124.76%). SSKN annual CFO is now -112.54% below its all-time high of $4.14 million, reached on 31 December 2017.SSKN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$302.00 K
-$893.00 K-151.10%
30 September 2024
Summary:
STRATA Skin Sciences quarterly cash flow from operations is currently -$302.00 thousand, with the most recent change of -$893.00 thousand (-151.10%) on 30 September 2024. Over the past year, it has increased by +$1.72 million (+85.05%). SSKN quarterly CFO is now -115.95% below its all-time high of $1.89 million, reached on 31 December 2017.SSKN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$856.00 K
+$1.72 M+199.30%
30 September 2024
Summary:
STRATA Skin Sciences TTM cash flow from operations is currently $856.00 thousand, with the most recent change of +$1.72 million (+199.30%) on 30 September 2024. Over the past year, it has increased by +$2.57 million (+150.03%). SSKN TTM CFO is now -79.32% below its all-time high of $4.14 million, reached on 31 December 2017.SSKN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SSKN Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +43.8% | +85.0% | +150.0% |
3 y3 years | -124.8% | -166.8% | -27.8% |
5 y5 years | -117.9% | -142.5% | -61.4% |
SSKN Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -124.8% | +43.8% | -122.0% | +85.0% | -43.2% | +150.0% |
5 y | 5 years | -117.9% | +43.8% | -122.0% | +85.0% | -71.7% | +150.0% |
alltime | all time | -112.5% | +97.3% | -116.0% | +95.8% | -79.3% | +104.2% |
STRATA Skin Sciences Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$302.00 K(-151.1%) | $856.00 K(-199.3%) |
June 2024 | - | $591.00 K(-173.5%) | -$862.00 K(+70.4%) |
Mar 2024 | - | -$804.00 K(-158.6%) | -$506.00 K(-2.5%) |
Dec 2023 | -$519.00 K(-43.8%) | $1.37 M(-167.9%) | -$519.00 K(-69.7%) |
Sept 2023 | - | -$2.02 M(-313.3%) | -$1.71 M(+344.4%) |
June 2023 | - | $947.00 K(-215.9%) | -$385.00 K(-72.3%) |
Mar 2023 | - | -$817.00 K(-556.4%) | -$1.39 M(+50.2%) |
Dec 2022 | -$924.00 K(-161.3%) | $179.00 K(-125.8%) | -$924.00 K(+112.9%) |
Sept 2022 | - | -$694.00 K(+1139.3%) | -$434.00 K(-161.0%) |
June 2022 | - | -$56.00 K(-84.1%) | $712.00 K(-28.9%) |
Mar 2022 | - | -$353.00 K(-152.8%) | $1.00 M(-33.6%) |
Dec 2021 | $1.51 M(-28.1%) | $669.00 K(+48.0%) | $1.51 M(+27.3%) |
Sept 2021 | - | $452.00 K(+93.2%) | $1.19 M(-7.6%) |
June 2021 | - | $234.00 K(+52.9%) | $1.28 M(-22.4%) |
Mar 2021 | - | $153.00 K(-55.8%) | $1.65 M(-21.2%) |
Dec 2020 | $2.10 M(-6.0%) | $346.00 K(-37.0%) | $2.10 M(-26.8%) |
Sept 2020 | - | $549.00 K(-9.0%) | $2.86 M(-5.3%) |
June 2020 | - | $603.00 K(+0.8%) | $3.02 M(+21.4%) |
Mar 2020 | - | $598.00 K(-46.3%) | $2.49 M(+11.8%) |
Dec 2019 | $2.23 M(-23.0%) | $1.11 M(+56.8%) | $2.23 M(+0.5%) |
Sept 2019 | - | $710.00 K(+914.3%) | $2.22 M(-34.2%) |
June 2019 | - | $70.00 K(-79.2%) | $3.37 M(+6.2%) |
Mar 2019 | - | $336.00 K(-69.5%) | $3.17 M(+9.5%) |
Dec 2018 | $2.90 M(-30.0%) | $1.10 M(-40.9%) | $2.90 M(-21.5%) |
Sept 2018 | - | $1.86 M(-1555.5%) | $3.69 M(+55.3%) |
June 2018 | - | -$128.00 K(-313.3%) | $2.38 M(-29.8%) |
Mar 2018 | - | $60.00 K(-96.8%) | $3.38 M(-18.3%) |
Dec 2017 | $4.14 M(+1185.7%) | $1.89 M(+245.0%) | $4.14 M(+13.4%) |
Sept 2017 | - | $549.00 K(-37.5%) | $3.65 M(+1.6%) |
June 2017 | - | $879.00 K(+7.5%) | $3.59 M(+41.7%) |
Mar 2017 | - | $818.00 K(-41.8%) | $2.54 M(+687.6%) |
Dec 2016 | $322.00 K(-104.9%) | $1.41 M(+186.9%) | $322.00 K(-145.4%) |
Sept 2016 | - | $490.00 K(-375.3%) | -$709.00 K(-72.6%) |
June 2016 | - | -$178.00 K(-87.2%) | -$2.59 M(-46.8%) |
Mar 2016 | - | -$1.40 M(-472.3%) | -$4.87 M(-26.0%) |
Dec 2015 | -$6.57 M | $375.00 K(-127.0%) | -$6.57 M(-34.2%) |
Sept 2015 | - | -$1.39 M(-43.4%) | -$9.99 M(-18.3%) |
June 2015 | - | -$2.45 M(-20.9%) | -$12.22 M(-10.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | -$3.10 M(+2.0%) | -$13.69 M(-22.7%) |
Dec 2014 | -$17.71 M(-8.8%) | -$3.04 M(-16.2%) | -$17.71 M(-4.6%) |
Sept 2014 | - | -$3.63 M(-7.4%) | -$18.57 M(-6.9%) |
June 2014 | - | -$3.92 M(-45.0%) | -$19.95 M(-2.4%) |
Mar 2014 | - | -$7.12 M(+82.6%) | -$20.44 M(+5.3%) |
Dec 2013 | -$19.41 M(+1.0%) | -$3.90 M(-22.1%) | -$19.41 M(-5.5%) |
Sept 2013 | - | -$5.01 M(+13.5%) | -$20.55 M(+0.3%) |
June 2013 | - | -$4.41 M(-27.6%) | -$20.50 M(+2.5%) |
Mar 2013 | - | -$6.09 M(+20.9%) | -$20.00 M(+4.0%) |
Dec 2012 | -$19.22 M(+10.1%) | -$5.04 M(+1.7%) | -$19.22 M(+5.7%) |
Sept 2012 | - | -$4.96 M(+26.6%) | -$18.18 M(+6.1%) |
June 2012 | - | -$3.91 M(-26.4%) | -$17.14 M(-6.4%) |
Mar 2012 | - | -$5.32 M(+33.1%) | -$18.30 M(+4.8%) |
Dec 2011 | -$17.46 M(-7.2%) | -$4.00 M(+2.0%) | -$17.46 M(-6.6%) |
Sept 2011 | - | -$3.92 M(-22.8%) | -$18.70 M(-3.2%) |
June 2011 | - | -$5.08 M(+13.5%) | -$19.31 M(+4.0%) |
Mar 2011 | - | -$4.47 M(-14.6%) | -$18.56 M(-1.4%) |
Dec 2010 | -$18.82 M(+8.8%) | -$5.24 M(+15.6%) | -$18.82 M(+1.1%) |
Sept 2010 | - | -$4.53 M(+4.7%) | -$18.62 M(-1.0%) |
June 2010 | - | -$4.33 M(-8.5%) | -$18.80 M(+3.2%) |
Mar 2010 | - | -$4.73 M(-6.0%) | -$18.21 M(+5.3%) |
Dec 2009 | -$17.30 M(+6.8%) | -$5.03 M(+6.8%) | -$17.30 M(+5.5%) |
Sept 2009 | - | -$4.71 M(+25.9%) | -$16.41 M(+4.2%) |
June 2009 | - | -$3.74 M(-2.0%) | -$15.75 M(-4.7%) |
Mar 2009 | - | -$3.82 M(-7.7%) | -$16.52 M(+2.0%) |
Dec 2008 | -$16.20 M(+46.7%) | -$4.14 M(+2.0%) | -$16.20 M(+9.7%) |
Sept 2008 | - | -$4.06 M(-10.2%) | -$14.77 M(+11.0%) |
June 2008 | - | -$4.51 M(+29.0%) | -$13.32 M(+12.4%) |
Mar 2008 | - | -$3.50 M(+29.4%) | -$11.85 M(+7.2%) |
Dec 2007 | -$11.05 M(+8.9%) | -$2.71 M(+4.2%) | -$11.05 M(+0.5%) |
Sept 2007 | - | -$2.60 M(-14.8%) | -$10.99 M(+2.8%) |
June 2007 | - | -$3.05 M(+12.7%) | -$10.69 M(+3.3%) |
Mar 2007 | - | -$2.70 M(+2.1%) | -$10.36 M(+2.1%) |
Dec 2006 | -$10.14 M(+72.9%) | -$2.65 M(+15.1%) | -$10.14 M(+35.3%) |
Sept 2006 | - | -$2.30 M(-15.1%) | -$7.50 M(+44.2%) |
June 2006 | - | -$2.71 M(+8.8%) | -$5.20 M(+108.8%) |
Mar 2006 | - | -$2.49 M | -$2.49 M |
Dec 2005 | -$5.87 M(+91.4%) | - | - |
Dec 2004 | -$3.06 M | - | - |
FAQ
- What is STRATA Skin Sciences annual cash flow from operations?
- What is the all time high annual CFO for STRATA Skin Sciences?
- What is STRATA Skin Sciences annual CFO year-on-year change?
- What is STRATA Skin Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for STRATA Skin Sciences?
- What is STRATA Skin Sciences quarterly CFO year-on-year change?
- What is STRATA Skin Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for STRATA Skin Sciences?
- What is STRATA Skin Sciences TTM CFO year-on-year change?
What is STRATA Skin Sciences annual cash flow from operations?
The current annual CFO of SSKN is -$519.00 K
What is the all time high annual CFO for STRATA Skin Sciences?
STRATA Skin Sciences all-time high annual cash flow from operations is $4.14 M
What is STRATA Skin Sciences annual CFO year-on-year change?
Over the past year, SSKN annual cash flow from operations has changed by +$405.00 K (+43.83%)
What is STRATA Skin Sciences quarterly cash flow from operations?
The current quarterly CFO of SSKN is -$302.00 K
What is the all time high quarterly CFO for STRATA Skin Sciences?
STRATA Skin Sciences all-time high quarterly cash flow from operations is $1.89 M
What is STRATA Skin Sciences quarterly CFO year-on-year change?
Over the past year, SSKN quarterly cash flow from operations has changed by +$1.72 M (+85.05%)
What is STRATA Skin Sciences TTM cash flow from operations?
The current TTM CFO of SSKN is $856.00 K
What is the all time high TTM CFO for STRATA Skin Sciences?
STRATA Skin Sciences all-time high TTM cash flow from operations is $4.14 M
What is STRATA Skin Sciences TTM CFO year-on-year change?
Over the past year, SSKN TTM cash flow from operations has changed by +$2.57 M (+150.03%)